12/30/2021, 1:10 PM (Source: TeleTrader)
more TeleTrader news

Biogen drops 6% as Samsung denies acquisition plans

Shares of Biogen Inc. dropped more than 6% in premarket trading on Thursday after Samsung Biologics denied Samsung Group is in talks to acquire the company.

Earlier, South Korean media reported that Samsung is in negotiations to acquire Biogen in a deal worth around $42 billion and that an agreement is highly likely to be reached.

Biogen plunged 6.41% to $241.75 at 7:08 am ET.

Baha Breaking News (BBN) / NP